title: Mechanism-based inactivation of CYP2B1 and its F-helix mutant by two tert-butyl acetylenic compounds: covalent modification of prosthetic heme versus apoprotein.
abstract: The mechanism-based inactivation of cytochrome CYP2B1 [wild type (WT)] and its Thr205 to Ala mutant (T205A) by tert-butylphenylacetylene (BPA) and tert-butyl 1-methyl-2-propynyl ether (BMP) in the reconstituted system was investigated. The inactivation of WT by BPA exhibited a k(inact)/K(I) value of 1343 min(-1)mM(-1) and a partition ratio of 1. The inactivation of WT by BMP exhibited a k(inact)/K(I) value of 33 min(-1)mM(-1) and a partition ratio of 10. Liquid chromatography/tandem mass spectrometry analysis (LC/MS/MS) of the WT revealed 1) inactivation by BPA resulted in the formation of a protein adduct with a mass increase equivalent to the mass of BPA plus one oxygen atom, and 2) inactivation by BMP resulted in the formation of multiple heme adducts that all exhibited a mass increase equivalent to BMP plus one oxygen atom. LC/MS/MS analysis indicated the formation of glutathione (GSH) conjugates by the reaction of GSH with the ethynyl moiety of BMP or BPA with the oxygen being added to the internal or terminal carbon. For the inactivation of T205A by BPA and BMP, the k(inact)/K(I) values were suppressed by 100- and 4-fold, respectively, and the partition ratios were increased 9- and 3.5-fold, respectively. Only one major heme adduct was detected following the inactivation of the T205A by BMP. These results show that the Thr205 in the F-helix plays an important role in the efficiency of the mechanism-based inactivation of CYP2B1 by BPA and BMP. Homology modeling and substrate docking studies were presented to facilitate the interpretation of the experimental results.
authors.affiliation: Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109-5632, USA.
authors.forename: Hsia-Lien
authors.initials: HL
authors.lastname: Lin
authors.forename: Haoming
authors.initials: H
authors.lastname: Zhang
authors.forename: Kathleen R
authors.initials: KR
authors.lastname: Noon
authors.forename: Paul F
authors.initials: PF
authors.lastname: Hollenberg
mesh_terms: D000114:Acetylene / Q000031:analogs & derivatives* / Q000494:pharmacology; D000480:Alkynes / Q000494:pharmacology*; D019943:Amino Acid Substitution; D001059:Apoproteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D020134:Catalytic Domain / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D019362:Cytochrome P-450 CYP2B1 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004987:Ethers / Q000494:pharmacology*; D005978:Glutathione / Q000378:metabolism; D006418:Heme / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D013058:Mass Spectrometry; D008958:Models, Molecular; D009154:Mutation / Q000187:drug effects*; D010100:Oxygen / Q000737:chemistry; D011487:Protein Conformation / Q000187:drug effects; D012995:Solubility; D021241:Spectrometry, Mass, Electrospray Ionization; D053719:Tandem Mass Spectrometry
chemical_list: C545118:4-tert-butylphenylacetylene; D000480:Alkynes; D001059:Apoproteins; D004791:Enzyme Inhibitors; D004987:Ethers; C493248:tert-butyl 1-methyl-2-propynyl ether; D006418:Heme; D019362:Cytochrome P-450 CYP2B1; D005978:Glutathione; D000114:Acetylene; D010100:Oxygen
references.citation: Drug Metab Dispos. 2003 Dec;31(12):1532-40
references.pmid: 14625350
references.citation: Biol Mass Spectrom. 1993 Jun;22(6):319-25
references.pmid: 8329460
references.citation: Nature. 1989 Jun 22;339(6226):632-4
references.pmid: 2733794
references.citation: Biochemistry. 2001 Nov 13;40(45):13456-65
references.pmid: 11695892
references.citation: J Pharmacol Exp Ther. 2004 Dec;311(3):855-63
references.pmid: 15302894
references.citation: Arch Biochem Biophys. 1998 Jun 15;354(2):295-302
references.pmid: 9637739
references.citation: J Pharmacol Exp Ther. 2003 Aug;306(2):744-51
references.pmid: 12721329
references.citation: J Med Chem. 1982 Oct;25(10):1174-9
references.pmid: 7143353
references.citation: J Pharmacol Exp Ther. 2002 Feb;300(2):549-58
references.pmid: 11805216
references.citation: Biochemistry. 2003 Feb 11;42(5):1245-53
references.pmid: 12564927
references.citation: J Biol Chem. 1988 Dec 15;263(35):18640-9
references.pmid: 3198593
references.citation: J Biol Chem. 1992 Jan 5;267(1):83-90
references.pmid: 1730627
references.citation: J Biol Chem. 1985 Mar 25;260(6):3330-6
references.pmid: 3972828
references.citation: Drug Metab Dispos. 2008 Nov;36(11):2234-43
references.pmid: 18653744
references.citation: Chem Res Toxicol. 2002 Dec;15(12):1561-71
references.pmid: 12482238
references.citation: J Pharmacol Exp Ther. 2003 Jan;304(1):477-87
references.pmid: 12490624
references.citation: Arch Biochem Biophys. 2004 May 1;425(1):95-105
references.pmid: 15081898
references.citation: Chem Res Toxicol. 1993 Jan-Feb;6(1):38-45
references.pmid: 8448348
references.citation: J Biol Chem. 1987 Jul 15;262(20):9793-802
references.pmid: 3597438
references.citation: Biochim Biophys Acta. 2007 Mar;1770(3):402-12
references.pmid: 16935426
references.citation: Proteins. 2002 Nov 1;49(2):216-31
references.pmid: 12211002
references.citation: Chem Res Toxicol. 1995 Jun;8(4):574-9
references.pmid: 7548737
references.citation: Curr Drug Metab. 2001 Jun;2(2):117-37
references.pmid: 11469721
references.citation: J Comput Aided Mol Des. 1996 Aug;10(4):293-304
references.pmid: 8877701
references.citation: Arch Biochem Biophys. 2001 Oct 1;394(1):21-8
references.pmid: 11566023
references.citation: J Pharmacol Exp Ther. 2007 Apr;321(1):276-87
references.pmid: 17251390
references.citation: J Biol Chem. 2004 Jun 25;279(26):27294-301
references.pmid: 15100217
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):71-9
references.pmid: 15178696
references.citation: J Biol Chem. 2006 Mar 3;281(9):5973-81
references.pmid: 16373351
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13196-201
references.pmid: 14563924
references.citation: J Pharmacol Exp Ther. 2002 Apr;301(1):160-7
references.pmid: 11907170
references.citation: Arch Biochem Biophys. 2005 Mar 1;435(1):157-65
references.pmid: 15680917
references.citation: Chem Res Toxicol. 2006 Feb;19(2):279-87
references.pmid: 16485904